{"id":"W2950630840","doi":"10.1097/01.hs9.0000560636.62389.3a","title":"PF587 SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE (SPD) IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"SAIT Polytechnic; Alberta Cancer Foundation; Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Tolerability; Lenalidomide; Medicine; Multiple myeloma; Refractory (planetary science); Dexamethasone; Internal medicine; Oncology; Bortezomib; Pharmacology; Phases of clinical research; Progressive disease; Adverse effect; Gastroenterology; Toxicity; Chemotherapy; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005999889,0.0003791745,0.00101629,0.0003251254,0.0003217809,0.0004332318,0.0002791329,0.0004510014,0.001266949],"category_scores_gemma":[0.000758115,0.0002094247,0.0005612789,0.0004294839,0.0002241059,0.0003549877,0.0002528459,0.0007725786,0.0002268012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007701298,"about_ca_system_score_gemma":0.0007323959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000921777,"about_ca_topic_score_gemma":0.003113288,"domain_scores_codex":[0.9997571,0.0000910355,0.00002670495,0.00004532358,0.00004096472,0.00003885444],"domain_scores_gemma":[0.9996997,0.0000610124,0.00007340036,0.000009666065,0.00001622882,0.00014007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1143398,0.005484896,0.5561159,0.001093912,0.001787637,0.007395915,0.0009649771,0.003026413,0.02097399,0.000309529,0.005433409,0.2830737],"study_design_scores_gemma":[0.02040238,0.127581,0.8147554,0.0002766721,0.002033228,0.01375888,0.0007183463,0.004641521,0.003336189,0.0006060865,0.0118194,0.000070774],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931816,0.004615625,0.00009079435,0.0005212576,0.00003808352,0.0001084408,0.000172068,0.00002081031,0.001251204],"genre_scores_gemma":[0.997731,0.001070174,0.0002451915,0.0003393182,0.00006309754,0.00004406914,0.0001940394,0.000002094636,0.0003108858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001266949,"threshold_uncertainty_score":0.005587757,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01371024063456188,"score_gpt":0.2593603018621555,"score_spread":0.2456500612275936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}